Global AAV-based Gene Therapy Products Supply, Demand and Key Producers, 2024-2030
Page: 145
Published Date: 28 Apr 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
AAV-based gene therapy products utilize adeno-associated virus (AAV) vectors as delivery vehicles to transfer therapeutic genes into target cells for the treatment of various genetic disorders and diseases. AAV vectors are non-pathogenic viruses that can efficiently infect a wide range of cells and have a low immunogenicity profile, making them suitable candidates for gene therapy applications. In AAV-based gene therapy, the therapeutic gene of interest is inserted into the AAV vector's genome, and the vector is then administered to the patient, typically via intravenous injection or direct injection into the affected tissue. Once inside the target cells, the AAV vector delivers the therapeutic gene, allowing it to be expressed and produce the desired therapeutic protein. AAV-based gene therapy products hold significant promise for the treatment of inherited genetic disorders, as well as acquired diseases such as certain types of cancer and neurodegenerative disorders, offering potential long-term therapeutic benefits with a single administration.
The global AAV-based Gene Therapy Products market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).
This report studies the global AAV-based Gene Therapy Products production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for AAV-based Gene Therapy Products and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of AAV-based Gene Therapy Products that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AAV-based Gene Therapy Products total production and demand, 2019-2030, (Units)
Global AAV-based Gene Therapy Products total production value, 2019-2030, (USD Million)
Global AAV-based Gene Therapy Products production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (Units), (based on production site)
Global AAV-based Gene Therapy Products consumption by region & country, CAGR, 2019-2030 & (Units)
U.S. VS China: AAV-based Gene Therapy Products domestic production, consumption, key domestic manufacturers and share
Global AAV-based Gene Therapy Products production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (Units)
Global AAV-based Gene Therapy Products production by Type, production, value, CAGR, 2019-2030, (USD Million) & (Units)
Global AAV-based Gene Therapy Products production by Application, production, value, CAGR, 2019-2030, (USD Million) & (Units)
This report profiles key players in the global AAV-based Gene Therapy Products market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include uniQure, Spark Therapeutics, AveXis (Novartis), PTC Therapeutics, BioMarin, Sarepta Therapeutics, Roche, Pfizer, CSL Behring, Sangamo Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World AAV-based Gene Therapy Products market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global AAV-based Gene Therapy Products Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global AAV-based Gene Therapy Products Market, Segmentation by Type:
AAV2
AAV8
AAV9
Others
Global AAV-based Gene Therapy Products Market, Segmentation by Application:
Haematology
Ophthalmology
Neurology
Musculoskeletal
Others
Companies Profiled:
uniQure
Spark Therapeutics
AveXis (Novartis)
PTC Therapeutics
BioMarin
Sarepta Therapeutics
Roche
Pfizer
CSL Behring
Sangamo Therapeutics
Biogen
Freeline Therapeutics
Coave Therapeutics
MeiraGTx
RegenxBio
Asklepios Biopharmaceutical
Audentes Therapeutics
Neurophth
Belief BioMed
Key Questions Answered:
1. How big is the global AAV-based Gene Therapy Products market?
2. What is the demand of the global AAV-based Gene Therapy Products market?
3. What is the year over year growth of the global AAV-based Gene Therapy Products market?
4. What is the production and production value of the global AAV-based Gene Therapy Products market?
5. Who are the key producers in the global AAV-based Gene Therapy Products market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 AAV-based Gene Therapy Products Introduction
1.2 World AAV-based Gene Therapy Products Supply & Forecast
1.2.1 World AAV-based Gene Therapy Products Production Value (2019 & 2023 & 2030)
1.2.2 World AAV-based Gene Therapy Products Production (2019-2030)
1.2.3 World AAV-based Gene Therapy Products Pricing Trends (2019-2030)
1.3 World AAV-based Gene Therapy Products Production by Region (Based on Production Site)
1.3.1 World AAV-based Gene Therapy Products Production Value by Region (2019-2030)
1.3.2 World AAV-based Gene Therapy Products Production by Region (2019-2030)
1.3.3 World AAV-based Gene Therapy Products Average Price by Region (2019-2030)
1.3.4 North America AAV-based Gene Therapy Products Production (2019-2030)
1.3.5 Europe AAV-based Gene Therapy Products Production (2019-2030)
1.3.6 China AAV-based Gene Therapy Products Production (2019-2030)
1.3.7 Japan AAV-based Gene Therapy Products Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 AAV-based Gene Therapy Products Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 AAV-based Gene Therapy Products Major Market Trends
2.1 World AAV-based Gene Therapy Products Demand (2019-2030)
2.2 World AAV-based Gene Therapy Products Consumption by Region
2.2.1 World AAV-based Gene Therapy Products Consumption by Region (2019-2024)
2.2.2 World AAV-based Gene Therapy Products Consumption Forecast by Region (2025-2030)
2.3 United States AAV-based Gene Therapy Products Consumption (2019-2030)
2.4 China AAV-based Gene Therapy Products Consumption (2019-2030)
2.5 Europe AAV-based Gene Therapy Products Consumption (2019-2030)
2.6 Japan AAV-based Gene Therapy Products Consumption (2019-2030)
2.7 South Korea AAV-based Gene Therapy Products Consumption (2019-2030)
2.8 ASEAN AAV-based Gene Therapy Products Consumption (2019-2030)
2.9 India AAV-based Gene Therapy Products Consumption (2019-2030)
3.1 World AAV-based Gene Therapy Products Production Value by Manufacturer (2019-2024)
3.2 World AAV-based Gene Therapy Products Production by Manufacturer (2019-2024)
3.3 World AAV-based Gene Therapy Products Average Price by Manufacturer (2019-2024)
3.4 AAV-based Gene Therapy Products Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global AAV-based Gene Therapy Products Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for AAV-based Gene Therapy Products in 2023
3.5.3 Global Concentration Ratios (CR8) for AAV-based Gene Therapy Products in 2023
3.6 AAV-based Gene Therapy Products Market: Overall Company Footprint Analysis
3.6.1 AAV-based Gene Therapy Products Market: Region Footprint
3.6.2 AAV-based Gene Therapy Products Market: Company Product Type Footprint
3.6.3 AAV-based Gene Therapy Products Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: AAV-based Gene Therapy Products Production Value Comparison
4.1.1 United States VS China: AAV-based Gene Therapy Products Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: AAV-based Gene Therapy Products Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: AAV-based Gene Therapy Products Production Comparison
4.2.1 United States VS China: AAV-based Gene Therapy Products Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: AAV-based Gene Therapy Products Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: AAV-based Gene Therapy Products Consumption Comparison
4.3.1 United States VS China: AAV-based Gene Therapy Products Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: AAV-based Gene Therapy Products Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based AAV-based Gene Therapy Products Manufacturers and Market Share, 2019-2024
4.4.1 United States Based AAV-based Gene Therapy Products Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers AAV-based Gene Therapy Products Production Value (2019-2024)
4.4.3 United States Based Manufacturers AAV-based Gene Therapy Products Production (2019-2024)
4.5 China Based AAV-based Gene Therapy Products Manufacturers and Market Share
4.5.1 China Based AAV-based Gene Therapy Products Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers AAV-based Gene Therapy Products Production Value (2019-2024)
4.5.3 China Based Manufacturers AAV-based Gene Therapy Products Production (2019-2024)
4.6 Rest of World Based AAV-based Gene Therapy Products Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based AAV-based Gene Therapy Products Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers AAV-based Gene Therapy Products Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers AAV-based Gene Therapy Products Production (2019-2024)
5.1 World AAV-based Gene Therapy Products Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 AAV2
5.2.2 AAV8
5.2.3 AAV9
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World AAV-based Gene Therapy Products Production by Type (2019-2030)
5.3.2 World AAV-based Gene Therapy Products Production Value by Type (2019-2030)
5.3.3 World AAV-based Gene Therapy Products Average Price by Type (2019-2030)
6.1 World AAV-based Gene Therapy Products Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Haematology
6.2.2 Ophthalmology
6.2.3 Neurology
6.2.4 Musculoskeletal
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World AAV-based Gene Therapy Products Production by Application (2019-2030)
6.3.2 World AAV-based Gene Therapy Products Production Value by Application (2019-2030)
6.3.3 World AAV-based Gene Therapy Products Average Price by Application (2019-2030)
7.1 uniQure
7.1.1 uniQure Details
7.1.2 uniQure Major Business
7.1.3 uniQure AAV-based Gene Therapy Products Product and Services
7.1.4 uniQure AAV-based Gene Therapy Products Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 uniQure Recent Developments/Updates
7.1.6 uniQure Competitive Strengths & Weaknesses
7.2 Spark Therapeutics
7.2.1 Spark Therapeutics Details
7.2.2 Spark Therapeutics Major Business
7.2.3 Spark Therapeutics AAV-based Gene Therapy Products Product and Services
7.2.4 Spark Therapeutics AAV-based Gene Therapy Products Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Spark Therapeutics Recent Developments/Updates
7.2.6 Spark Therapeutics Competitive Strengths & Weaknesses
7.3 AveXis (Novartis)
7.3.1 AveXis (Novartis) Details
7.3.2 AveXis (Novartis) Major Business
7.3.3 AveXis (Novartis) AAV-based Gene Therapy Products Product and Services
7.3.4 AveXis (Novartis) AAV-based Gene Therapy Products Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 AveXis (Novartis) Recent Developments/Updates
7.3.6 AveXis (Novartis) Competitive Strengths & Weaknesses
7.4 PTC Therapeutics
7.4.1 PTC Therapeutics Details
7.4.2 PTC Therapeutics Major Business
7.4.3 PTC Therapeutics AAV-based Gene Therapy Products Product and Services
7.4.4 PTC Therapeutics AAV-based Gene Therapy Products Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 PTC Therapeutics Recent Developments/Updates
7.4.6 PTC Therapeutics Competitive Strengths & Weaknesses
7.5 BioMarin
7.5.1 BioMarin Details
7.5.2 BioMarin Major Business
7.5.3 BioMarin AAV-based Gene Therapy Products Product and Services
7.5.4 BioMarin AAV-based Gene Therapy Products Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 BioMarin Recent Developments/Updates
7.5.6 BioMarin Competitive Strengths & Weaknesses
7.6 Sarepta Therapeutics
7.6.1 Sarepta Therapeutics Details
7.6.2 Sarepta Therapeutics Major Business
7.6.3 Sarepta Therapeutics AAV-based Gene Therapy Products Product and Services
7.6.4 Sarepta Therapeutics AAV-based Gene Therapy Products Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Sarepta Therapeutics Recent Developments/Updates
7.6.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
7.7 Roche
7.7.1 Roche Details
7.7.2 Roche Major Business
7.7.3 Roche AAV-based Gene Therapy Products Product and Services
7.7.4 Roche AAV-based Gene Therapy Products Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Roche Recent Developments/Updates
7.7.6 Roche Competitive Strengths & Weaknesses
7.8 Pfizer
7.8.1 Pfizer Details
7.8.2 Pfizer Major Business
7.8.3 Pfizer AAV-based Gene Therapy Products Product and Services
7.8.4 Pfizer AAV-based Gene Therapy Products Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Pfizer Recent Developments/Updates
7.8.6 Pfizer Competitive Strengths & Weaknesses
7.9 CSL Behring
7.9.1 CSL Behring Details
7.9.2 CSL Behring Major Business
7.9.3 CSL Behring AAV-based Gene Therapy Products Product and Services
7.9.4 CSL Behring AAV-based Gene Therapy Products Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 CSL Behring Recent Developments/Updates
7.9.6 CSL Behring Competitive Strengths & Weaknesses
7.10 Sangamo Therapeutics
7.10.1 Sangamo Therapeutics Details
7.10.2 Sangamo Therapeutics Major Business
7.10.3 Sangamo Therapeutics AAV-based Gene Therapy Products Product and Services
7.10.4 Sangamo Therapeutics AAV-based Gene Therapy Products Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Sangamo Therapeutics Recent Developments/Updates
7.10.6 Sangamo Therapeutics Competitive Strengths & Weaknesses
7.11 Biogen
7.11.1 Biogen Details
7.11.2 Biogen Major Business
7.11.3 Biogen AAV-based Gene Therapy Products Product and Services
7.11.4 Biogen AAV-based Gene Therapy Products Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Biogen Recent Developments/Updates
7.11.6 Biogen Competitive Strengths & Weaknesses
7.12 Freeline Therapeutics
7.12.1 Freeline Therapeutics Details
7.12.2 Freeline Therapeutics Major Business
7.12.3 Freeline Therapeutics AAV-based Gene Therapy Products Product and Services
7.12.4 Freeline Therapeutics AAV-based Gene Therapy Products Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Freeline Therapeutics Recent Developments/Updates
7.12.6 Freeline Therapeutics Competitive Strengths & Weaknesses
7.13 Coave Therapeutics
7.13.1 Coave Therapeutics Details
7.13.2 Coave Therapeutics Major Business
7.13.3 Coave Therapeutics AAV-based Gene Therapy Products Product and Services
7.13.4 Coave Therapeutics AAV-based Gene Therapy Products Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Coave Therapeutics Recent Developments/Updates
7.13.6 Coave Therapeutics Competitive Strengths & Weaknesses
7.14 MeiraGTx
7.14.1 MeiraGTx Details
7.14.2 MeiraGTx Major Business
7.14.3 MeiraGTx AAV-based Gene Therapy Products Product and Services
7.14.4 MeiraGTx AAV-based Gene Therapy Products Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 MeiraGTx Recent Developments/Updates
7.14.6 MeiraGTx Competitive Strengths & Weaknesses
7.15 RegenxBio
7.15.1 RegenxBio Details
7.15.2 RegenxBio Major Business
7.15.3 RegenxBio AAV-based Gene Therapy Products Product and Services
7.15.4 RegenxBio AAV-based Gene Therapy Products Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 RegenxBio Recent Developments/Updates
7.15.6 RegenxBio Competitive Strengths & Weaknesses
7.16 Asklepios Biopharmaceutical
7.16.1 Asklepios Biopharmaceutical Details
7.16.2 Asklepios Biopharmaceutical Major Business
7.16.3 Asklepios Biopharmaceutical AAV-based Gene Therapy Products Product and Services
7.16.4 Asklepios Biopharmaceutical AAV-based Gene Therapy Products Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 Asklepios Biopharmaceutical Recent Developments/Updates
7.16.6 Asklepios Biopharmaceutical Competitive Strengths & Weaknesses
7.17 Audentes Therapeutics
7.17.1 Audentes Therapeutics Details
7.17.2 Audentes Therapeutics Major Business
7.17.3 Audentes Therapeutics AAV-based Gene Therapy Products Product and Services
7.17.4 Audentes Therapeutics AAV-based Gene Therapy Products Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.17.5 Audentes Therapeutics Recent Developments/Updates
7.17.6 Audentes Therapeutics Competitive Strengths & Weaknesses
7.18 Neurophth
7.18.1 Neurophth Details
7.18.2 Neurophth Major Business
7.18.3 Neurophth AAV-based Gene Therapy Products Product and Services
7.18.4 Neurophth AAV-based Gene Therapy Products Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.18.5 Neurophth Recent Developments/Updates
7.18.6 Neurophth Competitive Strengths & Weaknesses
7.19 Belief BioMed
7.19.1 Belief BioMed Details
7.19.2 Belief BioMed Major Business
7.19.3 Belief BioMed AAV-based Gene Therapy Products Product and Services
7.19.4 Belief BioMed AAV-based Gene Therapy Products Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.19.5 Belief BioMed Recent Developments/Updates
7.19.6 Belief BioMed Competitive Strengths & Weaknesses
8.1 AAV-based Gene Therapy Products Industry Chain
8.2 AAV-based Gene Therapy Products Upstream Analysis
8.2.1 AAV-based Gene Therapy Products Core Raw Materials
8.2.2 Main Manufacturers of AAV-based Gene Therapy Products Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 AAV-based Gene Therapy Products Production Mode
8.6 AAV-based Gene Therapy Products Procurement Model
8.7 AAV-based Gene Therapy Products Industry Sales Model and Sales Channels
8.7.1 AAV-based Gene Therapy Products Sales Model
8.7.2 AAV-based Gene Therapy Products Typical Distributors
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World AAV-based Gene Therapy Products Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World AAV-based Gene Therapy Products Production Value by Region (2019-2024) & (USD Million)
Table 3. World AAV-based Gene Therapy Products Production Value by Region (2025-2030) & (USD Million)
Table 4. World AAV-based Gene Therapy Products Production Value Market Share by Region (2019-2024)
Table 5. World AAV-based Gene Therapy Products Production Value Market Share by Region (2025-2030)
Table 6. World AAV-based Gene Therapy Products Production by Region (2019-2024) & (Units)
Table 7. World AAV-based Gene Therapy Products Production by Region (2025-2030) & (Units)
Table 8. World AAV-based Gene Therapy Products Production Market Share by Region (2019-2024)
Table 9. World AAV-based Gene Therapy Products Production Market Share by Region (2025-2030)
Table 10. World AAV-based Gene Therapy Products Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World AAV-based Gene Therapy Products Average Price by Region (2025-2030) & (US$/Unit)
Table 12. AAV-based Gene Therapy Products Major Market Trends
Table 13. World AAV-based Gene Therapy Products Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (Units)
Table 14. World AAV-based Gene Therapy Products Consumption by Region (2019-2024) & (Units)
Table 15. World AAV-based Gene Therapy Products Consumption Forecast by Region (2025-2030) & (Units)
Table 16. World AAV-based Gene Therapy Products Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key AAV-based Gene Therapy Products Producers in 2023
Table 18. World AAV-based Gene Therapy Products Production by Manufacturer (2019-2024) & (Units)
Table 19. Production Market Share of Key AAV-based Gene Therapy Products Producers in 2023
Table 20. World AAV-based Gene Therapy Products Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global AAV-based Gene Therapy Products Company Evaluation Quadrant
Table 22. World AAV-based Gene Therapy Products Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and AAV-based Gene Therapy Products Production Site of Key Manufacturer
Table 24. AAV-based Gene Therapy Products Market: Company Product Type Footprint
Table 25. AAV-based Gene Therapy Products Market: Company Product Application Footprint
Table 26. AAV-based Gene Therapy Products Competitive Factors
Table 27. AAV-based Gene Therapy Products New Entrant and Capacity Expansion Plans
Table 28. AAV-based Gene Therapy Products Mergers & Acquisitions Activity
Table 29. United States VS China AAV-based Gene Therapy Products Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China AAV-based Gene Therapy Products Production Comparison, (2019 & 2023 & 2030) & (Units)
Table 31. United States VS China AAV-based Gene Therapy Products Consumption Comparison, (2019 & 2023 & 2030) & (Units)
Table 32. United States Based AAV-based Gene Therapy Products Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers AAV-based Gene Therapy Products Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers AAV-based Gene Therapy Products Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers AAV-based Gene Therapy Products Production (2019-2024) & (Units)
Table 36. United States Based Manufacturers AAV-based Gene Therapy Products Production Market Share (2019-2024)
Table 37. China Based AAV-based Gene Therapy Products Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers AAV-based Gene Therapy Products Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers AAV-based Gene Therapy Products Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers AAV-based Gene Therapy Products Production, (2019-2024) & (Units)
Table 41. China Based Manufacturers AAV-based Gene Therapy Products Production Market Share (2019-2024)
Table 42. Rest of World Based AAV-based Gene Therapy Products Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers AAV-based Gene Therapy Products Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers AAV-based Gene Therapy Products Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers AAV-based Gene Therapy Products Production, (2019-2024) & (Units)
Table 46. Rest of World Based Manufacturers AAV-based Gene Therapy Products Production Market Share (2019-2024)
Table 47. World AAV-based Gene Therapy Products Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World AAV-based Gene Therapy Products Production by Type (2019-2024) & (Units)
Table 49. World AAV-based Gene Therapy Products Production by Type (2025-2030) & (Units)
Table 50. World AAV-based Gene Therapy Products Production Value by Type (2019-2024) & (USD Million)
Table 51. World AAV-based Gene Therapy Products Production Value by Type (2025-2030) & (USD Million)
Table 52. World AAV-based Gene Therapy Products Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World AAV-based Gene Therapy Products Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World AAV-based Gene Therapy Products Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World AAV-based Gene Therapy Products Production by Application (2019-2024) & (Units)
Table 56. World AAV-based Gene Therapy Products Production by Application (2025-2030) & (Units)
Table 57. World AAV-based Gene Therapy Products Production Value by Application (2019-2024) & (USD Million)
Table 58. World AAV-based Gene Therapy Products Production Value by Application (2025-2030) & (USD Million)
Table 59. World AAV-based Gene Therapy Products Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World AAV-based Gene Therapy Products Average Price by Application (2025-2030) & (US$/Unit)
Table 61. uniQure Basic Information, Manufacturing Base and Competitors
Table 62. uniQure Major Business
Table 63. uniQure AAV-based Gene Therapy Products Product and Services
Table 64. uniQure AAV-based Gene Therapy Products Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. uniQure Recent Developments/Updates
Table 66. uniQure Competitive Strengths & Weaknesses
Table 67. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table 68. Spark Therapeutics Major Business
Table 69. Spark Therapeutics AAV-based Gene Therapy Products Product and Services
Table 70. Spark Therapeutics AAV-based Gene Therapy Products Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Spark Therapeutics Recent Developments/Updates
Table 72. Spark Therapeutics Competitive Strengths & Weaknesses
Table 73. AveXis (Novartis) Basic Information, Manufacturing Base and Competitors
Table 74. AveXis (Novartis) Major Business
Table 75. AveXis (Novartis) AAV-based Gene Therapy Products Product and Services
Table 76. AveXis (Novartis) AAV-based Gene Therapy Products Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. AveXis (Novartis) Recent Developments/Updates
Table 78. AveXis (Novartis) Competitive Strengths & Weaknesses
Table 79. PTC Therapeutics Basic Information, Manufacturing Base and Competitors
Table 80. PTC Therapeutics Major Business
Table 81. PTC Therapeutics AAV-based Gene Therapy Products Product and Services
Table 82. PTC Therapeutics AAV-based Gene Therapy Products Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. PTC Therapeutics Recent Developments/Updates
Table 84. PTC Therapeutics Competitive Strengths & Weaknesses
Table 85. BioMarin Basic Information, Manufacturing Base and Competitors
Table 86. BioMarin Major Business
Table 87. BioMarin AAV-based Gene Therapy Products Product and Services
Table 88. BioMarin AAV-based Gene Therapy Products Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. BioMarin Recent Developments/Updates
Table 90. BioMarin Competitive Strengths & Weaknesses
Table 91. Sarepta Therapeutics Basic Information, Manufacturing Base and Competitors
Table 92. Sarepta Therapeutics Major Business
Table 93. Sarepta Therapeutics AAV-based Gene Therapy Products Product and Services
Table 94. Sarepta Therapeutics AAV-based Gene Therapy Products Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Sarepta Therapeutics Recent Developments/Updates
Table 96. Sarepta Therapeutics Competitive Strengths & Weaknesses
Table 97. Roche Basic Information, Manufacturing Base and Competitors
Table 98. Roche Major Business
Table 99. Roche AAV-based Gene Therapy Products Product and Services
Table 100. Roche AAV-based Gene Therapy Products Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Roche Recent Developments/Updates
Table 102. Roche Competitive Strengths & Weaknesses
Table 103. Pfizer Basic Information, Manufacturing Base and Competitors
Table 104. Pfizer Major Business
Table 105. Pfizer AAV-based Gene Therapy Products Product and Services
Table 106. Pfizer AAV-based Gene Therapy Products Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Pfizer Recent Developments/Updates
Table 108. Pfizer Competitive Strengths & Weaknesses
Table 109. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 110. CSL Behring Major Business
Table 111. CSL Behring AAV-based Gene Therapy Products Product and Services
Table 112. CSL Behring AAV-based Gene Therapy Products Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. CSL Behring Recent Developments/Updates
Table 114. CSL Behring Competitive Strengths & Weaknesses
Table 115. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 116. Sangamo Therapeutics Major Business
Table 117. Sangamo Therapeutics AAV-based Gene Therapy Products Product and Services
Table 118. Sangamo Therapeutics AAV-based Gene Therapy Products Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Sangamo Therapeutics Recent Developments/Updates
Table 120. Sangamo Therapeutics Competitive Strengths & Weaknesses
Table 121. Biogen Basic Information, Manufacturing Base and Competitors
Table 122. Biogen Major Business
Table 123. Biogen AAV-based Gene Therapy Products Product and Services
Table 124. Biogen AAV-based Gene Therapy Products Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Biogen Recent Developments/Updates
Table 126. Biogen Competitive Strengths & Weaknesses
Table 127. Freeline Therapeutics Basic Information, Manufacturing Base and Competitors
Table 128. Freeline Therapeutics Major Business
Table 129. Freeline Therapeutics AAV-based Gene Therapy Products Product and Services
Table 130. Freeline Therapeutics AAV-based Gene Therapy Products Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Freeline Therapeutics Recent Developments/Updates
Table 132. Freeline Therapeutics Competitive Strengths & Weaknesses
Table 133. Coave Therapeutics Basic Information, Manufacturing Base and Competitors
Table 134. Coave Therapeutics Major Business
Table 135. Coave Therapeutics AAV-based Gene Therapy Products Product and Services
Table 136. Coave Therapeutics AAV-based Gene Therapy Products Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Coave Therapeutics Recent Developments/Updates
Table 138. Coave Therapeutics Competitive Strengths & Weaknesses
Table 139. MeiraGTx Basic Information, Manufacturing Base and Competitors
Table 140. MeiraGTx Major Business
Table 141. MeiraGTx AAV-based Gene Therapy Products Product and Services
Table 142. MeiraGTx AAV-based Gene Therapy Products Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. MeiraGTx Recent Developments/Updates
Table 144. MeiraGTx Competitive Strengths & Weaknesses
Table 145. RegenxBio Basic Information, Manufacturing Base and Competitors
Table 146. RegenxBio Major Business
Table 147. RegenxBio AAV-based Gene Therapy Products Product and Services
Table 148. RegenxBio AAV-based Gene Therapy Products Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. RegenxBio Recent Developments/Updates
Table 150. RegenxBio Competitive Strengths & Weaknesses
Table 151. Asklepios Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 152. Asklepios Biopharmaceutical Major Business
Table 153. Asklepios Biopharmaceutical AAV-based Gene Therapy Products Product and Services
Table 154. Asklepios Biopharmaceutical AAV-based Gene Therapy Products Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 155. Asklepios Biopharmaceutical Recent Developments/Updates
Table 156. Asklepios Biopharmaceutical Competitive Strengths & Weaknesses
Table 157. Audentes Therapeutics Basic Information, Manufacturing Base and Competitors
Table 158. Audentes Therapeutics Major Business
Table 159. Audentes Therapeutics AAV-based Gene Therapy Products Product and Services
Table 160. Audentes Therapeutics AAV-based Gene Therapy Products Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 161. Audentes Therapeutics Recent Developments/Updates
Table 162. Audentes Therapeutics Competitive Strengths & Weaknesses
Table 163. Neurophth Basic Information, Manufacturing Base and Competitors
Table 164. Neurophth Major Business
Table 165. Neurophth AAV-based Gene Therapy Products Product and Services
Table 166. Neurophth AAV-based Gene Therapy Products Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 167. Neurophth Recent Developments/Updates
Table 168. Neurophth Competitive Strengths & Weaknesses
Table 169. Belief BioMed Basic Information, Manufacturing Base and Competitors
Table 170. Belief BioMed Major Business
Table 171. Belief BioMed AAV-based Gene Therapy Products Product and Services
Table 172. Belief BioMed AAV-based Gene Therapy Products Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 173. Belief BioMed Recent Developments/Updates
Table 174. Belief BioMed Competitive Strengths & Weaknesses
Table 175. Global Key Players of AAV-based Gene Therapy Products Upstream (Raw Materials)
Table 176. Global AAV-based Gene Therapy Products Typical Customers
Table 177. AAV-based Gene Therapy Products Typical Distributors
List of Figures
Figure 1. AAV-based Gene Therapy Products Picture
Figure 2. World AAV-based Gene Therapy Products Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World AAV-based Gene Therapy Products Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World AAV-based Gene Therapy Products Production (2019-2030) & (Units)
Figure 5. World AAV-based Gene Therapy Products Average Price (2019-2030) & (US$/Unit)
Figure 6. World AAV-based Gene Therapy Products Production Value Market Share by Region (2019-2030)
Figure 7. World AAV-based Gene Therapy Products Production Market Share by Region (2019-2030)
Figure 8. North America AAV-based Gene Therapy Products Production (2019-2030) & (Units)
Figure 9. Europe AAV-based Gene Therapy Products Production (2019-2030) & (Units)
Figure 10. China AAV-based Gene Therapy Products Production (2019-2030) & (Units)
Figure 11. Japan AAV-based Gene Therapy Products Production (2019-2030) & (Units)
Figure 12. AAV-based Gene Therapy Products Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World AAV-based Gene Therapy Products Consumption (2019-2030) & (Units)
Figure 15. World AAV-based Gene Therapy Products Consumption Market Share by Region (2019-2030)
Figure 16. United States AAV-based Gene Therapy Products Consumption (2019-2030) & (Units)
Figure 17. China AAV-based Gene Therapy Products Consumption (2019-2030) & (Units)
Figure 18. Europe AAV-based Gene Therapy Products Consumption (2019-2030) & (Units)
Figure 19. Japan AAV-based Gene Therapy Products Consumption (2019-2030) & (Units)
Figure 20. South Korea AAV-based Gene Therapy Products Consumption (2019-2030) & (Units)
Figure 21. ASEAN AAV-based Gene Therapy Products Consumption (2019-2030) & (Units)
Figure 22. India AAV-based Gene Therapy Products Consumption (2019-2030) & (Units)
Figure 23. Producer Shipments of AAV-based Gene Therapy Products by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for AAV-based Gene Therapy Products Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for AAV-based Gene Therapy Products Markets in 2023
Figure 26. United States VS China: AAV-based Gene Therapy Products Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: AAV-based Gene Therapy Products Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: AAV-based Gene Therapy Products Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers AAV-based Gene Therapy Products Production Market Share 2023
Figure 30. China Based Manufacturers AAV-based Gene Therapy Products Production Market Share 2023
Figure 31. Rest of World Based Manufacturers AAV-based Gene Therapy Products Production Market Share 2023
Figure 32. World AAV-based Gene Therapy Products Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World AAV-based Gene Therapy Products Production Value Market Share by Type in 2023
Figure 34. AAV2
Figure 35. AAV8
Figure 36. AAV9
Figure 37. Others
Figure 38. World AAV-based Gene Therapy Products Production Market Share by Type (2019-2030)
Figure 39. World AAV-based Gene Therapy Products Production Value Market Share by Type (2019-2030)
Figure 40. World AAV-based Gene Therapy Products Average Price by Type (2019-2030) & (US$/Unit)
Figure 41. World AAV-based Gene Therapy Products Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 42. World AAV-based Gene Therapy Products Production Value Market Share by Application in 2023
Figure 43. Haematology
Figure 44. Ophthalmology
Figure 45. Neurology
Figure 46. Musculoskeletal
Figure 47. Others
Figure 48. World AAV-based Gene Therapy Products Production Market Share by Application (2019-2030)
Figure 49. World AAV-based Gene Therapy Products Production Value Market Share by Application (2019-2030)
Figure 50. World AAV-based Gene Therapy Products Average Price by Application (2019-2030) & (US$/Unit)
Figure 51. AAV-based Gene Therapy Products Industry Chain
Figure 52. AAV-based Gene Therapy Products Procurement Model
Figure 53. AAV-based Gene Therapy Products Sales Model
Figure 54. AAV-based Gene Therapy Products Sales Channels, Direct Sales, and Distribution
Figure 55. Methodology
Figure 56. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
uniQure Spark Therapeutics AveXis (Novartis) PTC Therapeutics BioMarin Sarepta Therapeutics Roche Pfizer CSL Behring Sangamo Therapeutics Biogen Freeline Therapeutics Coave Therapeutics MeiraGTx RegenxBio Asklepios Biopharmaceutical Audentes Therapeutics Neurophth Belief BioMed
28 Apr 2024
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
